A test for methicillin-resistant staphylococcus aureus has been registered in the Russian Federation

Rospotrebnadzor has registered a test for the determination of methicillin-resistant staphylococcus aureus.

Scientists at the Central Research Institute of Epidemiology of Rospotrebnadzor have developed and registered a new set of reagents for the rapid detection of methicillin-resistant staphylococcus aureus (MRSA) using the loop isothermal amplification (LAMP) method.

The new development makes it possible to identify genetic markers of antibiotic resistance, which will help doctors choose the most effective treatment methods.

The advantages of the new test include speed: the determination of staphylococcus aureus DNA and methicillin resistance genes takes only 20-25 minutes, as opposed to several hours with standard PCR analysis; convenience: the test can be performed on the same equipment as PCR, which simplifies its implementation in existing laboratories; accessibility: all components of the kit are manufactured in the country, this reduces dependence on imports and makes testing more accessible to the public.

The reagent kit is designed to analyze various human biomaterials, including whole venous blood, venous blood plasma, the first portion of urine, sputum, swabs from the oropharyngeal mucosa, flushes from environmental objects and cultures of microorganisms.

Thanks to the new development, Rospotrebnadzor receives an important tool to strengthen epidemiological surveillance of infections and reduce the risks of the spread of antibiotic-resistant microorganisms.

Primate environment: Monkey pox virus mutates and may become more contagious

How will changes in the genome affect the spread of infection

On March 20, researchers from the Yelyakov Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of the Russian Academy of Sciences (FEB RAS), Heilongjiang University and Ilan State University discovered a new method to increase the effectiveness of antibiotics used to treat bacterial infections. They found that a substance obtained from Pacific giant mussels enhances the effect of the drug gentamicin on Staphylococcus aureus and E. coli.